These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8145913)

  • 1. Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.
    Tawil R; McDermott MP; Mendell JR; Kissel J; Griggs RC
    Neurology; 1994 Mar; 44(3 Pt 1):442-6. PubMed ID: 8145913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.
    Personius KE; Pandya S; King WM; Tawil R; McDermott MP
    Phys Ther; 1994 Mar; 74(3):253-63. PubMed ID: 8115459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.
    Neurology; 1997 Jan; 48(1):38-46. PubMed ID: 9008491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of handedness on the distribution of muscular weakness of the arm in facioscapulohumeral muscular dystrophy.
    Brouwer OF; Padberg GW; van der Ploeg RJ; Ruys CJ; Brand R
    Brain; 1992 Oct; 115 ( Pt 5)():1587-98. PubMed ID: 1422805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.
    Tawil R; McDermott MP; Pandya S; King W; Kissel J; Mendell JR; Griggs RC
    Neurology; 1997 Jan; 48(1):46-9. PubMed ID: 9008492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy.
    Kilmer DD; Abresch RT; McCrory MA; Carter GT; Fowler WM; Johnson ER; McDonald CM
    Am J Phys Med Rehabil; 1995; 74(5 Suppl):S131-9. PubMed ID: 7576420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype/phenotype correlation. FSH-DY Group.
    Griggs RC; Tawil R; McDermott M; Forrester J; Figlewicz D; Weiffenbach B
    Muscle Nerve Suppl; 1995; 2():S50-5. PubMed ID: 7739626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The strength and functional performance in patients with facioscapulohumeral muscular dystrophy.
    Lue YJ; Chen SS
    Kaohsiung J Med Sci; 2000 May; 16(5):248-54. PubMed ID: 10969520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD).
    Goselink RJ; Schreuder TH; Mul K; Voermans NC; Pelsma M; de Groot IJ; van Alfen N; Franck B; Theelen T; Lemmers RJ; Mah JK; van der Maarel SM; van Engelen BG; Erasmus CE
    BMC Neurol; 2016 Aug; 16():138. PubMed ID: 27530735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.
    Tawil R; Forrester J; Griggs RC; Mendell J; Kissel J; McDermott M; King W; Weiffenbach B; Figlewicz D
    Ann Neurol; 1996 Jun; 39(6):744-8. PubMed ID: 8651646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beevor's sign and facioscapulohumeral dystrophy.
    Awerbuch GI; Nigro MA; Wishnow R
    Arch Neurol; 1990 Nov; 47(11):1208-9. PubMed ID: 2146943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (FSHD).
    Varma A; Todinca MS; Eichinger K; Heininger S; Dilek N; Martens W; Tawil R; Statland J; Kissel JT; McDermott MP; Heatwole C
    Muscle Nerve; 2024 Mar; 69(3):362-367. PubMed ID: 38189531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.
    Kissel JT; McDermott MP; Natarajan R; Mendell JR; Pandya S; King WM; Griggs RC; Tawil R
    Neurology; 1998 May; 50(5):1402-6. PubMed ID: 9595995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging.
    Monforte M; Laschena F; Ottaviani P; Bagnato MR; Pichiecchio A; Tasca G; Ricci E
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1258-1265. PubMed ID: 31668022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic status of patients with muscular dystrophy in early phase of the disease: In vitro, high resolution NMR spectroscopy based metabolomics analysis of serum.
    Srivastava NK; Annarao S; Sinha N
    Life Sci; 2016 Apr; 151():122-129. PubMed ID: 26930370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.
    Escolar DM; Henricson EK; Mayhew J; Florence J; Leshner R; Patel KM; Clemens PR
    Muscle Nerve; 2001 Jun; 24(6):787-93. PubMed ID: 11360262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hearing loss in facioscapulohumeral muscular dystrophy.
    Brouwer OF; Padberg GW; Ruys CJ; Brand R; de Laat JA; Grote JJ
    Neurology; 1991 Dec; 41(12):1878-81. PubMed ID: 1745341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.